Medigen Vaccine Biologics Corporation (6547.TWO)
TWD 34.1
(-1.45%)
TWD 34.1
(-1.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -477.75 Million | -1.1 Billion | 579.88 Million | -589.97 Million | -462.64 Million | -356.33 Million |
| Net Income | -1.15 Billion | -1.47 Billion | 1.41 Billion | -674.28 Million | -617.71 Million | -476.34 Million |
| Depreciation & Amortization | 131.17 Million | 127.89 Million | 112.54 Million | 122.25 Million | 118.48 Million | 101.02 Million |
| Deferred income taxes | -155.79 Million | - | -3.22 Million | -34.63 Million | -14.69 Million | -9.13 Million |
| Stock-based compensation | 18.3 Million | 75.6 Million | 68.81 Million | 44.65 Million | 28.92 Million | 19.36 Million |
| Change in working capital | 535.4 Million | 134.23 Million | -1.01 Billion | -60.06 Million | 2.85 Million | -4.31 Million |
| Other non-cash items | 152.99 Million | 35.87 Million | 3.27 Million | 12.1 Million | 19.5 Million | 13.07 Million |
| Investing Cash Flow | 669.82 Million | -2.39 Billion | -930.68 Million | -76.29 Million | 381.46 Million | -535.99 Million |
| Investments in PPE | -40.95 Million | -140.34 Million | -134.96 Million | -105.3 Million | -117.37 Million | -35.89 Million |
| Acquisitions | - | - | 120 Million | 29.69 Million | -719.78 Million | - |
| Investment purchases | -3.18 Billion | -2.27 Billion | -885 Million | -386 Thousand | 499.8 Million | -499.85 Million |
| Sales/Maturities of investments | 3.81 Billion | 15.99 Million | 1.1 Billion | -29.69 Million | 719.78 Million | - |
| Other Investing Activities | 74.4 Million | 5.91 Million | -1.13 Billion | 29.38 Million | -958 Thousand | -243 Thousand |
| Financing Cash Flow | 1.01 Million | 3.32 Billion | 51.17 Million | 1.93 Billion | 274.85 Million | 501.33 Million |
| Debt repayment | -581 Thousand | -1.75 Billion | -30 Million | -493.16 Million | -90.61 Million | -56.63 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 13.37 Million | 1.57 Billion | 55.67 Million | 2.4 Billion | 343.63 Million | 547.96 Million |
| Other Financing Activities | -11.77 Million | 3.49 Billion | 25.49 Million | 23.98 Million | 21.83 Million | 10 Million |
| Accounts receivables | 46.33 Million | 444.68 Million | -635.54 Million | -4.71 Million | 2.4 Million | - |
| Accounts payables | -82.63 Million | 21.71 Million | 65.62 Million | 19.28 Million | -2.4 Million | -3.75 Million |
| Inventory | 161.14 Million | 18.71 Million | -486.06 Million | -69.03 Million | 1.77 Million | -3.14 Million |
| Other working capital | 410.55 Million | -350.88 Million | 44.2 Million | -5.59 Million | 1.07 Million | -1.17 Million |
| Cash at beginning of period | 1.17 Billion | 1.37 Billion | 1.67 Billion | 410.62 Million | 217.07 Million | 608.06 Million |
| Cash at end of period | 1.35 Billion | 1.2 Billion | 1.37 Billion | 1.67 Billion | 410.62 Million | 217.07 Million |
| Capital Expenditure | -40.95 Million | -140.34 Million | -134.96 Million | -105.3 Million | -117.37 Million | -35.89 Million |
| Effect of forex changes on cash | -4.22 Million | 352 Thousand | -105 Thousand | -224 Thousand | -130 Thousand | - |
| Net cash flow / Change in cash | 173.7 Million | -175.43 Million | -299.73 Million | 1.26 Billion | 193.54 Million | -390.98 Million |
| Free Cash Flow | -518.7 Million | -1.24 Billion | 444.92 Million | -695.27 Million | -580.02 Million | -392.22 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 13.55 Million | -73.41 Million | -582.13 Million | -1.15 Billion | -52.03 Million | -313.5 Million |
| Depreciation & Amortization | 33.95 Million | 33.47 Million | 32.97 Million | 131.17 Million | 32.91 Million | 32.76 Million |
| Deferred income taxes | - | - | 374.81 Million | -155.79 Million | -2.9 Million | 1.61 Million |
| Stock-based compensation | 238 Thousand | 2.21 Million | 4.47 Million | 18.3 Million | -3.89 Million | 7.05 Million |
| Change in working capital | -172.05 Million | -25.85 Million | 564.08 Million | 535.4 Million | -74.72 Million | -61.28 Million |
| Other non-cash items | 247.2 Million | 81.06 Million | -365.98 Million | 152.99 Million | -8.23 Million | -12.65 Million |
| Investing Cash Flow | -715.12 Million | 2.24 Billion | 798.14 Million | 669.82 Million | -16.29 Million | 24.14 Million |
| Investments in PPE | -9.06 Million | -9.3 Million | -15.08 Million | -40.95 Million | -6.61 Million | -454 Thousand |
| Acquisitions | 171 Thousand | - | - | - | 65.32 Million | -1.37 Million |
| Investment purchases | -700.4 Million | -95.71 Million | 1000.00 | -3.18 Billion | -9.81 Million | -42.91 Million |
| Sales/Maturities of investments | - | 2.34 Billion | 800 Million | 3.81 Billion | -65.32 Million | 2.17 Million |
| Other Investing Activities | -5.83 Million | 192 Thousand | 13.22 Million | 74.4 Million | 143 Thousand | 66.71 Million |
| Financing Cash Flow | -1.72 Billion | -1.69 Million | -3.02 Million | 1.01 Million | 2.33 Million | -2.91 Million |
| Debt repayment | -1.72 Billion | -200 Thousand | -3.02 Million | -581 Thousand | -60 Thousand | -88.29 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.24 Million | 1.11 Million | - | 13.37 Million | 5.24 Million | - |
| Other Financing Activities | 1.24 Million | 1.11 Million | -3.02 Million | -11.77 Million | -2.85 Million | 85.37 Million |
| Accounts receivables | -126.82 Million | 86.1 Million | -31.08 Million | 46.33 Million | -117.26 Million | 3.24 Million |
| Accounts payables | -6.58 Million | -5.01 Million | 19.17 Million | -82.63 Million | -13.19 Million | -41.08 Million |
| Inventory | -65.79 Million | -23.93 Million | 457.13 Million | 161.14 Million | 41.19 Million | -342.35 Million |
| Other working capital | 27.14 Million | -83 Million | 118.86 Million | 410.55 Million | 14.54 Million | 318.9 Million |
| Cash at beginning of period | 3.63 Billion | 1.35 Billion | 498.48 Million | 1.17 Billion | 683.96 Million | 1.02 Billion |
| Cash at end of period | 327.25 Million | 3.63 Billion | 1.35 Billion | 1.35 Billion | 538.65 Million | 683.96 Million |
| Capital Expenditure | -9.06 Million | -9.3 Million | -15.08 Million | -40.95 Million | -6.61 Million | -454 Thousand |
| Effect of forex changes on cash | 46 Thousand | 140 Thousand | 31.12 Million | -4.22 Million | -22.47 Million | -12.84 Million |
| Net cash flow / Change in cash | -3.31 Billion | 2.28 Billion | 854.43 Million | 173.7 Million | -145.31 Million | -337.63 Million |
| Free Cash Flow | -153.5 Million | -3.83 Million | 13.13 Million | -518.7 Million | -115.49 Million | -346.46 Million |
5226
HLOSF
BAY
GLCO
XAM
SWP